{
  "abstract": "Asthma is one of the commonest long term diseases, affecting around 8% of the population in the UK, Europe, and North America.12 However, about one third of people categorised as having the disease are misdiagnosed,3 largely because objective testing is poorly utilised, and diagnostic tests may not be available in primary care where asthma is most commonly diagnosed.",
  "authors": [
    {
      "affiliations": [
        "Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK",
        "Manchester Academic Health Science Centre and NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester"
      ],
      "name": "Stephen J Fowler"
    },
    {
      "affiliations": [
        "Alder Hey Children’s NHS Foundation Trust, Liverpool",
        "Division of Child Health, University of Liverpool"
      ],
      "name": "Ian Sinha"
    },
    {
      "affiliations": [
        "Health and Care, Jersey"
      ],
      "name": "Matt Doyle"
    },
    {
      "affiliations": [
        "Patient representative"
      ],
      "name": "Sheba Joseph"
    },
    {
      "affiliations": [
        "National Institute for Health and Care Excellence, London"
      ],
      "name": "Alfredo Mariani"
    },
    {
      "affiliations": [
        "National Institute for Health and Care Excellence, London"
      ],
      "name": "Toby Sands"
    },
    {
      "affiliations": [],
      "name": "on behalf of the Guideline Development Group and BTS/NICE/SIGN Steering Group members"
    }
  ],
  "title": "Asthma: diagnosis, monitoring, and chronic asthma management: summary of guidance from BTS/NICE/SIGN",
  "uid": "797170ca-fb9a-50d8-b55a-9a929292844c"
}